Publications by authors named "S L Spurgeon"

In situ and (scanning) transmission electron microscopy [(S)TEM] is a powerful characterization technique that uses imaging, diffraction, and spectroscopy to gain nano-to-atomic scale insights into the structure-property relationships in materials. This technique is both customizable and complex because many factors impact the ability to collect structural, compositional, and bonding information from a sample during environmental exposure or under application of an external stimulus. In the past two decades, in situ and (S)TEM methods have diversified and grown to encompass additional capabilities, higher degrees of precision, dynamic tracking abilities, enhanced reproducibility, and improved analytical tools.

View Article and Find Full Text PDF

Understanding how doping influences physicochemical properties of ABO perovskite oxides is critical for tailoring their functionalities. In this study, SrFeCrO epitaxial thin films were used to examine the effects of Fe and Cr competition on structure and B-site cation oxidation states. The films exhibit a perovskite-like structure near the film/substrate interface, while a brownmillerite-like structure with horizontal oxygen vacancy channels predominates near the surface.

View Article and Find Full Text PDF

The shallow donor in zinc oxide (ZnO) is a promising semiconductor spin qubit with optical access. Single indium donors are isolated in a commercial ZnO substrate using plasma focused ion beam (PFIB) milling. Quantum emitters are identified optically by spatial and frequency filtering.

View Article and Find Full Text PDF
Article Synopsis
  • Bruton tyrosine kinase inhibitors (BTKis) like ibrutinib, used for lymphoid malignancies, can lead to new or worsening hypertension (HTN), raising concerns about optimal treatment methods.
  • A study of 196 patients divided them into two groups: those with pre-existing HTN and those who developed it after starting BTKis; results showed different antihypertensive strategies were effective for each group.
  • Patients with prior HTN benefited from a combination of β blockers and hydrochlorothiazide, while those with new HTN responded well to ACE inhibitors or ARBs combined with hydrochlorothiazide, suggesting a need for tailored treatments and further research.
View Article and Find Full Text PDF